Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,25%
1 104,10
+2,73
+0,25%
1 101,371 103,631 105,311 091,41
SIXC
Communications
SIXC
Communications
SIXC
-1,50%
604,16
-9,19
-1,50%
613,35613,35613,35601,49
SIXE
Energy
SIXE
Energy
SIXE
-0,09%
1 197,81
-1,02
-0,09%
1 198,831 199,681 199,751 182,41
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 740,41
-15,54
-0,88%
1 755,951 754,061 756,031 734,69
SIXM
Financials
SIXM
Financials
SIXM
-0,64%
634,44
-4,07
-0,64%
638,51637,41637,41633,05
SIXR
Staples
SIXR
Staples
SIXR
-0,31%
840,90
-2,62
-0,31%
843,52843,35846,40837,93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,38%
215,13
-0,82
-0,38%
215,95215,95216,84215,06
SIXT
Technology
SIXT
Technology
SIXT
+2,86%
3 228,71
+89,80
+2,86%
3 138,913 189,303 230,853 174,76
SIXU
Utilities
SIXU
Utilities
SIXU
+0,16%
935,87
+1,50
+0,16%
934,37934,72938,26927,50
SIXV
Health care
SIXV
Health care
SIXV
-1,37%
1 457,12
-20,31
-1,37%
1 477,431 474,121 474,121 451,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,83%
2 399,84
+19,65
+0,83%
2 380,192 389,342 403,042 380,47
CGEN:NASDAQ
Compugen Ltd
3,10 US$
+6,16%
(+0,18) 1K
3,14 US$
+1,29% (+0,040)
Yopilgandan keyin
Savdolar yopilgan: 24-apr, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
CGEN tikeri uchun statistika yaratilmoqda...
Ochish
3,00 US$
Yuqori
3,24 US$
Past
2,95 US$
Bozor kapitali
293,12 mln
Oʻrtacha hajm
352,24 ming
Hajmi
1,25 mln
P/E koeffitsiyenti
8,23
52 haftalik eng yuqori
3,24 US$
52 haftalik eng past
1,23 US$
Aksiya boʻyicha daromad
0,38 US$
Beta
2,77
Muomaladagi aksiyalar
94,55 mln
Xodimlar soni
75
Yangiliklar
Internetdagi manbalardan
Profil
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
Compugen Ltd haqida
CEOAnat Cohen-Dayag
Xodimlar soni75
Asos solingan10-fev, 1993
Bosh ofislar-
Sektor-
Veb-saytcgen.com
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
2,28 mln
1,26 mln
1,89 mln
67,33 mln
Sotilgan mahsulotning tannarxi
2,40 mln
1,66 mln
1,65 mln
3,54 mln
Daromad narxi
2,40 mln
1,66 mln
1,65 mln
3,54 mln
Tadqiqot va ishlanmalarga xarajatlar
5,77 mln
5,64 mln
5,80 mln
5,54 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
2,51 mln
2,38 mln
2,33 mln
2,21 mln
Operatsion xarajatlar
8,28 mln
8,02 mln
8,13 mln
7,75 mln
Jami operatsion xarajatlar
10,68 mln
9,69 mln
9,78 mln
11,29 mln
Operatsion daromad
-8,40 mln
-8,43 mln
-7,89 mln
56,04 mln
Boshqa nooperatsion daromad
-
-
-
-28,00 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-7,15 mln
-7,36 mln
-6,94 mln
56,84 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-7,15 mln
-7,36 mln
-6,94 mln
56,34 mln
Daromad soligʻi boʻyicha xarajat
31,00 ming
-17,00 ming
40,00 ming
-
Amaldagi soliq stavkasi
-0,43%
0,23%
-0,58%
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-7,18 mln
-7,34 mln
-6,98 mln
56,84 mln
Sof foyda marjasi
-314,40%
-584,09%
-369,06%
84,42%
Har bir aksiya foydasi
-0,08
-0,08
-0,07
0,60
Foizlar va investitsiyalardan olingan daromadlar
1,24 mln
1,07 mln
954,00 ming
636,00 ming
Foizlarni toʻlash xarajatlari
-
-
-
-
Foizlarni toʻlash boʻyicha sof xarajatlar
1,24 mln
1,07 mln
954,00 ming
636,00 ming
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-8,27 mln
-8,31 mln
-7,77 mln
56,16 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil